<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Bioeng. Biotechnol.</journal-id>
<journal-title>Frontiers in Bioengineering and Biotechnology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Bioeng. Biotechnol.</abbrev-journal-title>
<issn pub-type="epub">2296-4185</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1130523</article-id>
<article-id pub-id-type="doi">10.3389/fbioe.2023.1130523</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Bioengineering and Biotechnology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Magnetic iron oxide nanoparticle-loaded hydrogels for photothermal therapy of cancer cells</article-title>
<alt-title alt-title-type="left-running-head">Ji and Wang</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fbioe.2023.1130523">10.3389/fbioe.2023.1130523</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ji</surname>
<given-names>Yunfei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wang</surname>
<given-names>Chunpu</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2149993/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Critical Care Medicine</institution>, <institution>Chengde Central Hospital</institution>, <addr-line>Chengde</addr-line>, <addr-line>Hebei</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Cardiothoracic Surgery</institution>, <institution>Chengde Central Hospital</institution>, <addr-line>Chengde</addr-line>, <addr-line>Hebei</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1323121/overview">Yu Luo</ext-link>, Shanghai University of Engineering Sciences, China</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1415991/overview">Xiaojun Zhou</ext-link>, Donghua University, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/688411/overview">Ricardo Jo&#xe3;o Borges Pinto</ext-link>, University of Aveiro, Portugal</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Chunpu Wang, <email>W13703146012@126.com</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Nanobiotechnology, a section of the journal Frontiers in Bioengineering and Biotechnology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>16</day>
<month>03</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>11</volume>
<elocation-id>1130523</elocation-id>
<history>
<date date-type="received">
<day>23</day>
<month>12</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>09</day>
<month>03</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Ji and Wang.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Ji and Wang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>
<bold>Introduction:</bold> Non-invasive photothermal therapy (PTT) is a competitive treatment for solid tumors, while the efficacy is largely dependent on the effective retention of photothermal converters in tumor tissues.</p>
<p>
<bold>Methods:</bold> Herein, the development of iron oxide (Fe<sub>3</sub>O<sub>4</sub>) nanoparticle-loaded alginate (ALG) hydrogel platform for PTT of colorectal cancer cells is reported. Fe<sub>3</sub>O<sub>4</sub> nanoparticles synthesized <italic>via</italic> coprecipitation method after reaction of 30 min have a small size (61.3 nm) and more suitable surface potential, and can mediate PTT under near-infrared (NIR) laser irradiation. The premix of Fe<sub>3</sub>O<sub>4</sub> nanoparticles and ALG hydrogel precursors can be gelatinized by Ca<sup>2&#x002B;</sup>-mediated cross-linking to form this therapeutic hydrogel platform.</p>
<p>
<bold>Results:</bold> The formed Fe<sub>3</sub>O<sub>4</sub> nanoparticles can be effectively taken up by CT26 cancer cells and induce the death of CT26 cells <italic>in vitro</italic> under NIR laser irradiation because of their excellent photothermal property. In addition, Fe<sub>3</sub>O<sub>4</sub> nanoparticle-loaded ALG hydrogels show negligible cytotoxicity at the studied concentration range, but can significantly kill cancer cells after PTT effect.</p>
<p>
<bold>Conclusion:</bold> This ALG-based hydrogel platform provides a valuable reference for subsequent in vivo studies and other related studies on Fe<sub>3</sub>O<sub>4</sub> nanoparticle-loaded hydrogels.</p>
</abstract>
<kwd-group>
<kwd>iron oxide nanoparticles</kwd>
<kwd>hydrogels</kwd>
<kwd>cancer therapy</kwd>
<kwd>photothermal therapy</kwd>
<kwd>light</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Cancer has long been one of the most lethal diseases that threat human health (<xref ref-type="bibr" rid="B20">Navya et al., 2019</xref>; <xref ref-type="bibr" rid="B7">Ding et al., 2022</xref>; <xref ref-type="bibr" rid="B13">Jing et al., 2022</xref>). Although surgery, chemotherapy, and radiotherapy are the mainstays of cancer treatment in the past, their limitations such as low specificity and high risk of recurrence, have forced researchers to divert their attention beyond these traditional treatments to explore more effective therapy (<xref ref-type="bibr" rid="B19">Meng et al., 2020</xref>; <xref ref-type="bibr" rid="B4">Caballero et al., 2022</xref>). Photothermal therapy (PTT) is a very promising cancer treatment modality emerging in recent years (<xref ref-type="bibr" rid="B26">Zhang et al., 2020</xref>; <xref ref-type="bibr" rid="B8">Dong et al., 2021</xref>). Utilizing photothermal converters to capture and transform external light, the local heat generated during PTT can induce intracellular protein denaturation and apoptosis. Especially for tumor tissues with dense blood vessels and hindered heat dissipation, PTT is an extremely promising method for tumor ablation (<xref ref-type="bibr" rid="B6">Cristofolini et al., 2016</xref>). Gold nanoparticles, carbon-based nanomaterials, and some small-molecule dyes have been used as photothermal agents for cancer PTT (<xref ref-type="bibr" rid="B18">Liu et al., 2007</xref>; <xref ref-type="bibr" rid="B3">Bardhan et al., 2011</xref>; <xref ref-type="bibr" rid="B9">Espinosa et al., 2016</xref>). Unfortunately, the applications of most of these materials are limited due to their low retention and potential toxicity (<xref ref-type="bibr" rid="B9">Espinosa et al., 2016</xref>). Therefore, it is very important to explore safe and degradable photothermal agents. Biodegradable iron oxide (Fe<sub>3</sub>O<sub>4</sub>) nanoparticles have been approved by the Food and Drug Administration (FDA) as a magnetic resonance imaging (MRI) contrast agent. In addition, the strong absorption of Fe<sub>3</sub>O<sub>4</sub> nanoparticles in the near-infrared (NIR) window can be utilized for PTT (<xref ref-type="bibr" rid="B23">Shubayev et al., 2009</xref>; <xref ref-type="bibr" rid="B2">Anselmo and Mitragotri, 2015</xref>).</p>
<p>In general, many nanoparticles after intravenous injection are readily taken up by macrophages in the blood circulation and cleared by the reticuloendothelial system, thus hindering the aggregation of nanoparticles in tumors (<xref ref-type="bibr" rid="B16">Li et al., 2014</xref>). Therefore, the reliability of the carriers is of great significance for the performance of the anti-tumor ability of the nano-formulations. Hydrogels are a burgeoning class of three-dimensional polymer networks (<xref ref-type="bibr" rid="B11">Griffin et al., 2015</xref>; <xref ref-type="bibr" rid="B24">Vegas et al., 2016</xref>; <xref ref-type="bibr" rid="B21">Puiggal&#xed;-Jou et al., 2021</xref>). As a drug delivery system, hydrogels can not only release drugs controllably to fully exert anticancer efficacy, but also obviously weaken systemic toxicity in the form of intravenous administration. In addition, such hydrogel-based therapeutic platforms can reduce the numbers of drug administrations while maintaining biosafety (<xref ref-type="bibr" rid="B1">Almawash et al., 2022</xref>). Currently, alginate (ALG)-based hydrogels have enabled great advances in biomedicine due to their non-immunogenicity, excellent biocompatibility, and mild gel-forming conditions. ALG is a natural linear anionic polymer that can crosslink with divalent cations to form hydrogels (<xref ref-type="bibr" rid="B15">Lee and Mooney, 2012</xref>; <xref ref-type="bibr" rid="B17">Liu et al., 2021</xref>). By mixing with ALG hydrogel precursors and forming hydrogels after injection, many hydrophilic drugs and nanoparticles can be easily loaded and aggregated in tumor tissues with a relatively longer residence time after administration to exert therapeutic effects (<xref ref-type="bibr" rid="B14">Kim and Martin, 2006</xref>; <xref ref-type="bibr" rid="B10">Goncalves et al., 2014</xref>). However, the use of ALG hydrogels for loading of Fe<sub>3</sub>O<sub>4</sub> nanoparticles for effective cancer PTT has not been explored.</p>
<p>In this work, a Fe<sub>3</sub>O<sub>4</sub> nanoparticle-loaded hydrogel (Fe<sub>3</sub>O<sub>4</sub> hydrogel) was constructed for cancer PTT. Fe<sub>3</sub>O<sub>4</sub> nanoparticles were synthesized by chemical synthesis and mixed with ALG hydrogel precursors to form a homogeneous injectable solution. The Fe<sub>3</sub>O<sub>4</sub> hydrogel was then successfully prepared <italic>in vitro</italic> by mixing with Ca<sup>2&#x2b;</sup> solution at a concentration similar to that in biological tissues. After NIR irradiation, the cell viability of CT26 cells co-incubated with Fe<sub>3</sub>O<sub>4</sub> hydrogels was significantly lower than that in the control group, and the photothermal killing ability of the Fe<sub>3</sub>O<sub>4</sub> hydrogels was not shielded by the ALG hydrogel carrier. The Fe<sub>3</sub>O<sub>4</sub> nanoparticle-loaded hydrogels reported in this study significantly inhibited the viability of colorectal cancer cells.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>2 Materials and methods</title>
<sec id="s2-1">
<title>2.1 Materials</title>
<p>Ferrous chloride tetrahydrate (FeCl<sub>2</sub> 4H<sub>2</sub>O), ferric chloride hexahydrate (FeCl<sub>3</sub> 6H<sub>2</sub>O), sodium hydroxide (NaOH) and ALG were purchased from Shanghai Sinopharm Chemical Reagent Co., RPMI 1640 cell culture medium, fetal bovine serum (FBS), and penicillin-streptomycin were obtained from Gibco (Grand Island, NY, United States). Cell counting kit-8 (CCK-8) was purchased from Dojindo Laboratories (Kumamoto, Japan). Ultrapure water used in the experiments was prepared using a water purification system (PALL Cascada, MI, United States).</p>
</sec>
<sec id="s2-2">
<title>2.2 Characterization techniques</title>
<p>The UV-visible spectra of Fe<sub>3</sub>O<sub>4</sub> nanoparticles were characterized by Persee spectrophotometer (TU-1810, Beijing, China). The surface morphologies of Fe<sub>3</sub>O<sub>4</sub> hydrogels were observed using a scanning electron microscope (SEM, HITACHI, Japan). The hydrodynamic diameters and zeta potentials of Fe<sub>3</sub>O<sub>4</sub> nanoparticles were measured using a Zetasizer Nano-series (Nano-ZS90, Malvern, United Kingdom). The Fe concentrations were measured by using an inductively coupled plasma atomic emission spectroscopy (ICP-AES) system (Hudson, NH, United States).</p>
</sec>
<sec id="s2-3">
<title>2.3 Synthesis of Fe<sub>3</sub>O<sub>4</sub> nanoparticles</title>
<p>Fe<sub>3</sub>O<sub>4</sub> nanoparticles were synthesized according to a previous report (<xref ref-type="bibr" rid="B12">Hu et al., 2015</xref>). In brief, 178&#xa0;mg FeCl<sub>2</sub> 4H<sub>2</sub>O and 314&#xa0;mg FeCl<sub>3</sub> 6H<sub>2</sub>O were dissolved in deionized (DI) water. Then 10&#xa0;mL of NaOH solution (200&#xa0;mg/mL) was added to the above solution. After mixing well, the solution was placed in a water bath at 80&#xb0;C for 30&#xa0;min or 2&#xa0;h, respectively. The obtained samples were used to evaluate the influence of the reaction times on the properties of the nanoparticles. Subsequently, the mixed solution was placed on a magnetic stirrer to precipitate the synthesized Fe<sub>3</sub>O<sub>4</sub> nanoparticles, and the upper liquid was discarded. Then Fe<sub>3</sub>O<sub>4</sub> nanoparticles were dispersed in 10&#xa0;mL water under sonication. The above steps were repeated at least 5 times to purify the Fe<sub>3</sub>O<sub>4</sub> nanoparticles.</p>
</sec>
<sec id="s2-4">
<title>2.4 Synthesis of Fe<sub>3</sub>O<sub>4</sub> hydrogels</title>
<p>To prepare Fe<sub>3</sub>O<sub>4</sub> hydrogels, Fe<sub>3</sub>O<sub>4</sub> nanoparticles were mixed with ALG solution to obtain AF mixture solution and the solution was then injected into Ca<sup>2&#x2b;</sup> (1.8&#xa0;mM) solution. AF solutions at different concentrations of ALG (0.5, 1, 2.5, 5, 10&#xa0;&#x3bc;g/mL) were slowly injected into the Ca<sup>2&#x2b;</sup> solution (1.8&#xa0;mM). Then photographs were taken at different times after injection of solutions.</p>
</sec>
<sec id="s2-5">
<title>2.5 Evaluation of <italic>in vitro</italic> photothermal effect</title>
<p>To evaluate the photothermal properties of Fe<sub>3</sub>O<sub>4</sub> nanoparticles and Fe<sub>3</sub>O<sub>4</sub> hydrogels, 200&#xa0;&#x3bc;L of Fe<sub>3</sub>O<sub>4</sub> solution or Fe<sub>3</sub>O<sub>4</sub> hydrogels at the Fe concentration of 200&#xa0;&#x3bc;g/mL were placed in a 96-well plate. Then, 808&#xa0;nm laser at different power densities (0.5, 1.0, and 1.5&#xa0;W/cm<sup>2</sup>) was used to irradiate the solutions for 5&#xa0;min. Thermal images of solutions were obtained using a thermal infrared camera and the temperatures of the solution were recorded under laser irradiation. To investigate the effect of Fe concentrations on the photothermal properties, Fe<sub>3</sub>O<sub>4</sub> nanoparticles or Fe<sub>3</sub>O<sub>4</sub> hydrogels at different Fe concentrations (100, 200, 350, 500&#xa0;&#x3bc;g/mL) were irradiated by 808&#xa0;nm laser (1&#xa0;W/cm<sup>2</sup>) for 5&#xa0;min. DI water was used as the control group. These solutions were irradiated by a laser at the power density of 1&#xa0;W/cm<sup>2</sup>. The laser was turned on/off every 5&#xa0;min for 50&#xa0;min to evaluate the photothermal stability of Fe<sub>3</sub>O<sub>4</sub> nanoparticles and Fe<sub>3</sub>O<sub>4</sub> hydrogels.</p>
</sec>
<sec id="s2-6">
<title>2.6 Evaluation of <italic>in vitro</italic> cellular uptake</title>
<p>CT26 cancer cells were cultured in RPMI 1640 cell medium containing penicillin, streptomycin and 10% FBS at 37&#xb0;C and 5% CO<sub>2</sub>. The cells were incubated with Fe<sub>3</sub>O<sub>4</sub> nanoparticles at the Fe concentration of 100&#xa0;&#x3bc;g/mL for different time. The cellular uptake efficacy was evaluated using ICP-AES.</p>
</sec>
<sec id="s2-7">
<title>2.7 Evaluation of <italic>in vitro</italic> cytotoxicity</title>
<p>The cytotoxicity of CT26 cancer cells after incubation with Fe<sub>3</sub>O<sub>4</sub> nanoparticles or Fe<sub>3</sub>O<sub>4</sub> hydrogels was investigated using the CCK-8 assay. CT26 cancer cells were cultured with 100&#xa0;&#x3bc;L of fresh cell culture medium in 96-well plates (10,000 cells per well) and incubated for 24&#xa0;h. The cell culture medium was then discarded and Fe<sub>3</sub>O<sub>4</sub> solutions or Fe<sub>3</sub>O<sub>4</sub> hydrogels (1&#xa0;&#x3bc;g/mL for ALG) at different Fe concentrations (25, 50, 100, 200 and 400&#xa0;&#x3bc;g/mL) were added into the cell culture medium. Meanwhile, 1&#xa0;&#x3bc;L of Ca<sup>2&#x2b;</sup> solution (180&#xa0;mM) was added into the wells containing Fe<sub>3</sub>O<sub>4</sub> nanoparticles and ALG to form Fe<sub>3</sub>O<sub>4</sub> hydrogels. After the incubation of cells for 24&#xa0;h, the cell culture medium was discarded and the cells were carefully washed with PBS to remove free Fe<sub>3</sub>O<sub>4</sub> nanoparticles. Cell culture medium containing 10% CCK-8 agent was then added into each well. After incubation of the cells for 2&#xa0;h, the absorbance value of each well at 450&#xa0;nm was detected using a microplate reader. The cells treated with PBS were used as a control. The ratio of absorbance values was used to calculate cell viability.</p>
</sec>
<sec id="s2-8">
<title>2.8 Evaluation of <italic>in vitro</italic> therapeutic efficacy</title>
<p>To evaluate the therapeutic effect of Fe<sub>3</sub>O<sub>4</sub> nanoparticles and Fe<sub>3</sub>O<sub>4</sub> hydrogels, CT26 cancer cells were seeded in 96-well plates (10,000 cells per well) and incubated at 37&#xb0;C and 5% CO<sub>2</sub> for 24&#xa0;h. For Fe<sub>3</sub>O<sub>4</sub> nanoparticle treatment group, the cell culture medium was discarded and 10&#xa0;&#x3bc;L Fe<sub>3</sub>O<sub>4</sub> nanoparticles at the Fe concentration of 200&#xa0;&#x3bc;g/mL was added into each well containing 190&#xa0;&#x3bc;L&#xa0;cell culture medium. For Fe<sub>3</sub>O<sub>4</sub> hydrogel treatment group, the cell culture medium was discarded, and 10&#xa0;&#x3bc;L solution of Fe<sub>3</sub>O<sub>4</sub> nanoparticles (200&#xa0;&#x3bc;g/mL) and ALG (the concentration of ALG was 1&#xa0;&#x3bc;g/mL) was added into each well containing 189&#xa0;&#x3bc;L&#xa0;cell culture medium, and then 1&#xa0;&#x3bc;L of Ca<sup>2&#x2b;</sup> solution (180&#xa0;mM) was added into the wells to form Fe<sub>3</sub>O<sub>4</sub> hydrogels. The formed hydrogels could stick to cells for cell incubation. After incubation of cells for 12 h, the cells were irradiated by 808&#xa0;nm laser (1&#xa0;W/cm<sup>2</sup>) for 5&#xa0;min. After that, the cells were incubated for another 12&#xa0;h and the hydrogels were removed, and then cell viability was detected by CCK-8 assay.</p>
</sec>
<sec id="s2-9">
<title>2.9 Statistical analysis</title>
<p>Significant difference between the experimental statistics is analyzed by One-way ANOVA and indicated as (&#x2a;), <italic>p</italic> &#x3c; 0.01 by (&#x2a;&#x2a;) and <italic>p</italic> &#x3c; 0.001 by (&#x2a;&#x2a;&#x2a;).</p>
</sec>
</sec>
<sec sec-type="results|discussion" id="s3">
<title>3 Results and discussion</title>
<sec id="s3-1">
<title>3.1 Synthesis and characterization of Fe<sub>3</sub>O<sub>4</sub> nanoparticles</title>
<p>To investigate the effect of different reaction times on the properties of Fe<sub>3</sub>O<sub>4</sub> nanoparticles, the hydrodynamic sizes and surface zeta potentials of the Fe<sub>3</sub>O<sub>4</sub> nanoparticles formed after the reaction for 30&#xa0;min or 2&#xa0;h were measured. The hydrodynamic diameter of Fe<sub>3</sub>O<sub>4</sub> nanoparticles with 30&#xa0;min of reaction was 61.3&#xa0;nm, which was much smaller than that of 2&#xa0;h (1,624&#xa0;nm) (<xref ref-type="fig" rid="F1">Figures 1A, B</xref>). Meanwhile, the surface zeta potential of Fe<sub>3</sub>O<sub>4</sub> nanoparticles formed <italic>via</italic> a 30&#xa0;min reaction (&#x2212;21.4&#xa0;mV) was lower than that of 2&#xa0;h (&#x2212;6.8&#xa0;mV) (<xref ref-type="fig" rid="F1">Figure 1C</xref>). These results indicated that the Fe<sub>3</sub>O<sub>4</sub> nanoparticles obtained by reacting for 30&#xa0;min had a smaller diameter and a more suitable surface potential. The Fe<sub>3</sub>O<sub>4</sub> nanoparticles formed <italic>via</italic> a 30&#xa0;min of reaction had a smaller size, and thus they would show a higher stability. Stronger steric stabilization and less electrostatic stabilization may lead to their lower surface potential (<xref ref-type="bibr" rid="B22">Shah et al., 2014</xref>). Therefore, the reaction time was set at 30&#xa0;min in the following study. In addition, the UV-Vis absorption spectra of Fe<sub>3</sub>O<sub>4</sub> nanoparticles were evaluated (<xref ref-type="fig" rid="F1">Figure 1D</xref>). The absorbance value at 850&#xa0;nm increased with increasing Fe concentrations measured using ICP-AES, which could enable their PTT applications (<xref ref-type="bibr" rid="B25">Yang et al., 2017</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Characterization of Fe<sub>3</sub>O<sub>4</sub> nanoparticles. <bold>(A,B)</bold> Hydrodynamic diameter. <bold>(C)</bold> The zeta potential of Fe<sub>3</sub>O<sub>4</sub> nanoparticles obtained for a reaction time of 30&#xa0;min or 2&#xa0;h. <bold>(D)</bold> UV-visible spectra of Fe<sub>3</sub>O<sub>4</sub> nanoparticles with different Fe concentrations.</p>
</caption>
<graphic xlink:href="fbioe-11-1130523-g001.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>3.2 Evaluation of the photothermal conversion efficacy of Fe<sub>3</sub>O<sub>4</sub> nanoparticles</title>
<p>To evaluate the photothermal conversion efficacy, the Fe<sub>3</sub>O<sub>4</sub> nanoparticle solutions were irradiated by an 808&#xa0;nm laser. The thermal images were captured and the temperatures of the solutions were recorded. At the same Fe concentration, the temperatures of the solutions gradually increased with increasing laser time, which reached a maximum after 5&#xa0;min of laser irradiation (<xref ref-type="fig" rid="F2">Figure 2A</xref>). In order to evaluate the relationship between different power densities and the temperature increases, lasers at different power densities (0.5, 1, 1.5&#xa0;W/cm<sup>2</sup>) were used. Higher power densities achieved a greater increase in solution temperatures. The solution temperature increased to 35.5, 42.3, and 43.5&#xb0;C after 5&#xa0;min of laser irradiation at the power densities of 0.5, 1, and 1.5&#xa0;W/cm<sup>2</sup>, respectively (<xref ref-type="fig" rid="F2">Figure 2B</xref>). The solutions at different Fe concentrations showed different degrees of temperature increases after irradiation by 808&#xa0;nm laser (1&#xa0;W/cm<sup>2</sup>) for the same time (<xref ref-type="fig" rid="F2">Figure 2C</xref>). The temperature of solutions at Fe concentrations of 100, 200, 350, and 500&#xa0;&#x3bc;g/mL increased to 37.0, 42.3, 47.3, 55.0&#xb0;C, respectively (<xref ref-type="fig" rid="F2">Figure 2D</xref>). In contrast, the temperature of PBS solution showed no significant change after laser irradiation. The photothermal stability of Fe<sub>3</sub>O<sub>4</sub> nanoparticles was then evaluated. After five cycles of heating and natural cooling, the temperature increases of the Fe<sub>3</sub>O<sub>4</sub> nanoparticle solutions did not change significantly, indicating their good photothermal stability.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Evaluation of photothermal conversion efficiency. <bold>(A)</bold> Thermal imaging of Fe<sub>3</sub>O<sub>4</sub> nanoparticle solution under 808&#xa0;nm laser irradiation at power densities of 0.5, 1.0, and 1.5&#xa0;W/cm<sup>2</sup>. <bold>(B)</bold> Temperature profiles of Fe<sub>3</sub>O<sub>4</sub> nanoparticle solution under different power densities of 808&#xa0;nm laser irradiation. <bold>(C)</bold> Thermal imaging of Fe<sub>3</sub>O<sub>4</sub> nanoparticle solutions at concentrations of 100, 200, 350, and 500&#xa0;&#x3bc;g/mL under 808&#xa0;nm laser irradiation at a power density of 1.0&#xa0;W/cm<sup>2</sup>. <bold>(D)</bold> Temperature profiles of Fe<sub>3</sub>O<sub>4</sub> nanoparticle solutions at different concentrations under 808&#xa0;nm laser (1.0&#xa0;W/cm<sup>2</sup>) irradiation. <bold>(E)</bold> The photothermal stability evaluation of the Fe<sub>3</sub>O<sub>4</sub> nanoparticle solutions after 5 laser cycles.</p>
</caption>
<graphic xlink:href="fbioe-11-1130523-g002.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>3.3 Preparation and characterization of Fe<sub>3</sub>O<sub>4</sub> hydrogels</title>
<p>To prepare Fe<sub>3</sub>O<sub>4</sub> hydrogels, Fe<sub>3</sub>O<sub>4</sub> nanoparticles were added to ALG solutions at different concentrations (0.5, 1, 2.5, 5, 10&#xa0;mg/mL) and the solutions were slowly injected into 10&#xa0;mL Ca<sup>2&#x2b;</sup> solution (1.8&#xa0;mM). The hydrogels could be formed <italic>via</italic> cross-linking of ALG by Ca<sup>2&#x2b;</sup>. The rate of hydrogel formation increased with the increasing of ALG concentrations (<xref ref-type="fig" rid="F3">Figure 3A</xref>). When the solution with a ALG concentration of 0.5, 1 or 2.5&#xa0;mg/mL was injected into the Ca<sup>2&#x2b;</sup> solution, hydrogels could be formed. However, the formed hydrogels disintegrated rapidly in solution due to the low cross-linkage of the formed hydrogels. When the concentration of ALG was 5 or 10&#xa0;mg/mL, the formed hydrogels were able to maintain stability state for a long time without significant morphological changes due to the high cross-linking degree. Therefore, the concentration of ALG was set at 5&#xa0;mg/mL in the following experiments. The SEM images showed that nanoparticles were attached to the surface of the hydrogels, which proved that Fe<sub>3</sub>O<sub>4</sub> nanoparticles could be effectively encapsulated into the hydrogels (<xref ref-type="fig" rid="F3">Figures 3B, C</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Characterization of Fe<sub>3</sub>O<sub>4</sub> hydrogels. <bold>(A)</bold> Photographs of AF solutions at different ALG concentrations injected into Ca<sup>2&#x2b;</sup> solutions at different times. <bold>(B,C)</bold> SEM images of Fe<sub>3</sub>O<sub>4</sub> hydrogels.</p>
</caption>
<graphic xlink:href="fbioe-11-1130523-g003.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>3.4 Evaluation of photothermal conversion efficacy of Fe<sub>3</sub>O<sub>4</sub> hydrogels</title>
<p>The Fe<sub>3</sub>O<sub>4</sub> hydrogels were irradiated using an 808&#xa0;nm laser to study their photothermal conversion properties. The thermal images were captured and temperatures of the hydrogels were recorded. The temperatures of Fe<sub>3</sub>O<sub>4</sub> hydrogel solutions gradually increased with the increasing of laser irradiation time, which reached the maximum after laser irradiation for 5&#xa0;min (<xref ref-type="fig" rid="F4">Figure 4A</xref>). Meanwhile, the temperatures of the hydrogel solutions irradiated by 808&#xa0;nm laser at different power densities (0.5, 1, 1.5&#xa0;W/cm<sup>2</sup>) for 5&#xa0;min were different. The solution temperature increased to 35.1, 41.3, and 43.9&#xb0;C after 5&#xa0;min of laser irradiation at power densities of 0.5, 1, and 1.5&#xa0;W/cm<sup>2</sup>, respectively (<xref ref-type="fig" rid="F4">Figure 4B</xref>), indicating that higher power densities could achieve better photothermal effects. The temperature increases of the Fe<sub>3</sub>O<sub>4</sub> hydrogel solutions were not significantly different for power density of 1 and 1.5&#xa0;W/cm<sup>2</sup>, so the power density used in the subsequent experiments was set at 1&#xa0;W/cm<sup>2</sup>. The photothermal performance of Fe<sub>3</sub>O<sub>4</sub> hydrogels at different Fe concentrations was also evaluated. After 5&#xa0;min of 808&#xa0;nm (1&#xa0;W/cm<sup>2</sup>) laser irradiation, the temperature of the hydrogel solutions at Fe concentrations of 100, 200, 350, and 500&#xa0;&#x3bc;g/mL increased to 34.6, 41.3, 46.4, and 55.2&#xb0;C, respectively (<xref ref-type="fig" rid="F4">Figures 4C, D</xref>). These concentrations were used for photothermal effect evaluation because the Fe<sub>3</sub>O<sub>4</sub> nanoparticles at these concentration ranges could obviously increase temperatures under laser irradiation (<xref ref-type="bibr" rid="B5">Chen et al., 2023</xref>). Meanwhile, the photothermal stability of the Fe<sub>3</sub>O<sub>4</sub> hydrogels was evaluated (<xref ref-type="fig" rid="F4">Figure 4E</xref>). The temperature increase did not change significantly after five cycles of heating/cooling, indicating that the Fe<sub>3</sub>O<sub>4</sub> hydrogels had good photothermal stability. There was no significant difference between the photothermal performance of Fe<sub>3</sub>O<sub>4</sub> hydrogels and Fe<sub>3</sub>O<sub>4</sub> nanoparticles, indicating that the loading of Fe<sub>3</sub>O<sub>4</sub> nanoparticles into hydrogels did not affect their photothermal performance.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Evaluation of photothermal conversion efficiency of Fe<sub>3</sub>O<sub>4</sub> hydrogels. <bold>(A)</bold> Thermal imaging of Fe<sub>3</sub>O<sub>4</sub> hydrogels under 808&#xa0;nm laser irradiation at power densities of 0.5, 1.0, and 1.5&#xa0;W/cm<sup>2</sup>. <bold>(B)</bold> Temperature profiles of Fe<sub>3</sub>O<sub>4</sub> hydrogels under 808&#xa0;nm laser irradiation at different power densities. <bold>(C)</bold> Thermal imaging of hydrogels at concentrations of 100, 200, 350, and 500&#xa0;&#x3bc;g/mL under 808&#xa0;nm laser irradiation at a power density of 1.0&#xa0;W/cm<sup>2</sup>. <bold>(D)</bold> Temperature profiles of Fe<sub>3</sub>O<sub>4</sub> hydrogels at different concentrations under 808&#xa0;nm laser (1.0&#xa0;W/cm<sup>2</sup>) irradiation. <bold>(E)</bold> The photothermal stability evaluation of Fe<sub>3</sub>O<sub>4</sub> hydrogels after 5 laser cycles.</p>
</caption>
<graphic xlink:href="fbioe-11-1130523-g004.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>3.5 Evaluation of <italic>in vitro</italic> treatment efficiency</title>
<p>The <italic>in vitro</italic> cellular uptake of Fe<sub>3</sub>O<sub>4</sub> nanoparticles by cancer cells was evaluated using ICP-AES. The cellular uptake of Fe<sub>3</sub>O<sub>4</sub> nanoparticles was pivotal to induce therapeutic effect for Fe<sub>3</sub>O<sub>4</sub> nanoparticle-treated cells. After incubation the cells with Fe<sub>3</sub>O<sub>4</sub> nanoparticles, the Fe uptake in cancer cells gradually increased in a time dependent manner (<xref ref-type="fig" rid="F5">Figure 5A</xref>). After 24&#xa0;h, the cellular Fe level increased by 6.6-fold. These results suggested the effective cellular uptake of Fe<sub>3</sub>O<sub>4</sub> nanoparticles by cancer cells. To evaluate the cytotoxicity, CT26 cancer cells were co-incubated with Fe<sub>3</sub>O<sub>4</sub> nanoparticles or Fe<sub>3</sub>O<sub>4</sub> hydrogels for 24&#xa0;h. The cell viability of CT26 cells was higher than 92.5% after incubation with Fe<sub>3</sub>O<sub>4</sub> nanoparticles or Fe<sub>3</sub>O<sub>4</sub> hydrogels even when the Fe concentration was as high as 400&#xa0;&#x3bc;g/mL (<xref ref-type="fig" rid="F5">Figure 5B</xref>), indicating that both Fe<sub>3</sub>O<sub>4</sub> nanoparticles and Fe<sub>3</sub>O<sub>4</sub> hydrogels had good biosafety and cytocompatibility. The <italic>in vitro</italic> therapeutic effects of Fe<sub>3</sub>O<sub>4</sub> nanoparticles and Fe<sub>3</sub>O<sub>4</sub> hydrogels were then evaluated using CCK-8 assay. CT26 cancer cells were irradiated by 808&#xa0;nm laser (1&#xa0;W/cm<sup>2</sup>) for 5&#xa0;min, and the cell viability was not significantly reduced compared to that in the control group, indicating that cancer cells were not killed by laser irradiation alone (<xref ref-type="fig" rid="F5">Figure 5C</xref>). When CT26 cells were treated with Fe<sub>3</sub>O<sub>4</sub> nanoparticles or Fe<sub>3</sub>O<sub>4</sub> hydrogels plus laser irradiation, the cell activity of cells decreased to 16.1% and 15.4%, respectively. The cell vitality of cells in Fe<sub>3</sub>O<sub>4</sub> nanoparticles &#x2b; laser and Fe<sub>3</sub>O<sub>4</sub> hydrogels &#x2b; laser was similar. These results verified the therapeutic effect of Fe<sub>3</sub>O<sub>4</sub> hydrogels. Although the therapeutic efficacy of Fe<sub>3</sub>O<sub>4</sub> hydrogels was similar to that of Fe<sub>3</sub>O<sub>4</sub> nanoparticles, the Fe<sub>3</sub>O<sub>4</sub> hydrogels could maintain a high concentration at injected sites and obviously reduce systemic toxicity in the form of intravenous administration, which would contribute to their future <italic>in vivo</italic> studies.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>
<italic>In vitro</italic> treatment efficacy evaluation. <bold>(A)</bold> Cellular uptake assay of Fe<sub>3</sub>O<sub>4</sub> nanoparticles by CT26 cancer cells. <bold>(B)</bold> Cell viability of CT26 cancer cells after treatment with Fe<sub>3</sub>O<sub>4</sub> nanoparticles or Fe<sub>3</sub>O<sub>4</sub> hydrogels at different Fe concentrations for 24&#xa0;h. <bold>(C)</bold> Cell viability of CT26 cancer cells after incubation with PBS, Fe<sub>3</sub>O<sub>4</sub> nanoparticles, or Fe<sub>3</sub>O<sub>4</sub> hydrogels with or without 808&#xa0;nm laser irradiation (1.0&#xa0;W/cm<sup>2</sup>, 5&#xa0;min).</p>
</caption>
<graphic xlink:href="fbioe-11-1130523-g005.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="conclusion" id="s4">
<title>4 Conclusion</title>
<p>Herein, we report the development of Fe<sub>3</sub>O<sub>4</sub> nanoparticle-loaded hydrogel platform (Fe<sub>3</sub>O<sub>4</sub> hydrogels) for PTT of colon cancer cells. The synthesis of Fe<sub>3</sub>O<sub>4</sub> nanoparticles could be achieved after 30&#xa0;min of reaction, and the formed Fe<sub>3</sub>O<sub>4</sub> nanoparticles showed a smaller diameter, a more suitable surface potential and a good photothermal conversion efficacy under 808&#xa0;nm laser irradiation. The cross-linking of ALG solutions containing Fe<sub>3</sub>O<sub>4</sub> nanoparticles by Ca<sup>2&#x2b;</sup> led to the formation of Fe<sub>3</sub>O<sub>4</sub> hydrogels. The obtained Fe<sub>3</sub>O<sub>4</sub> hydrogels also showed a high photothermal conversion efficiency under 808&#xa0;nm laser irradiation. Both Fe<sub>3</sub>O<sub>4</sub> nanoparticles and Fe<sub>3</sub>O<sub>4</sub> hydrogels were found to have good cytocompatibility. <italic>In vitro</italic> therapeutic efficacy evaluation showed that the PTT effect mediated by Fe<sub>3</sub>O<sub>4</sub> nanoparticle-loaded hydrogels could obviously kill CT26 cancer cells, which was similar to that of Fe<sub>3</sub>O<sub>4</sub> nanoparticles. Although Fe<sub>3</sub>O<sub>4</sub> nanoparticles have been used for cancer PTT, we for the first time report the uses of Fe<sub>3</sub>O<sub>4</sub> nanoparticle-loaded hydrogels for effective PTT. In view of the different characteristics of Fe<sub>3</sub>O<sub>4</sub> nanoparticles, such as imaging, magnetism, and Fenton reaction, this platform may also be used for combinational therapy of cancer.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6">
<title>Author contributions</title>
<p>CW: Corresponding authors, conception, design of the study and revising the manuscript; YJ: acquisition, analysis, interpretation of the data, and drafting the article. All authors read and approved the final manuscript.</p>
</sec>
<sec id="s7">
<title>Funding</title>
<p>This study was supported by the Chengde Central Hospital.</p>
</sec>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Almawash</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Osman</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Mustafa</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>El Hamd</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Current and future prospective of injectable hydrogels-design challenges and limitations</article-title>. <source>Pharmaceuticals</source> <volume>15</volume>, <fpage>371</fpage>. <pub-id pub-id-type="doi">10.3390/ph15030371</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anselmo</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Mitragotri</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>A review of clinical translation of inorganic nanoparticles</article-title>. <source>AAPS J.</source> <volume>17</volume>, <fpage>1041</fpage>&#x2013;<lpage>1054</lpage>. <pub-id pub-id-type="doi">10.1208/s12248-015-9780-2</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bardhan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lal</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Joshi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Halas</surname>
<given-names>N. J.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Theranostic nanoshells: From probe design to imaging and treatment of cancer</article-title>. <source>Acc. Chem. Res.</source> <volume>44</volume>, <fpage>936</fpage>&#x2013;<lpage>946</lpage>. <pub-id pub-id-type="doi">10.1021/ar200023x</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caballero</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Abreu</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Lima</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Neves</surname>
<given-names>N. N.</given-names>
</name>
<name>
<surname>Reis</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Kundu</surname>
<given-names>S. C.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Precision biomaterials in cancer theranostics and modelling</article-title>. <source>Biomaterials</source> <volume>280</volume>, <fpage>121299</fpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2021.121299</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Tumor acidic microenvironment-responsive promodulator iron oxide nanoparticles for photothermal-enhanced chemodynamic immunotherapy of cancer</article-title>. <source>ACS Biomater. Sci. Eng.</source> <volume>9</volume>, <fpage>773</fpage>&#x2013;<lpage>783</lpage>. <pub-id pub-id-type="doi">10.1021/acsbiomaterials.2c01287</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cristofolini</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Szczepanowicz</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Orsi</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Rimoldi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Albertini</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Warszynski</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Hybrid polyelectrolyte/Fe<sub>3</sub>O<sub>4</sub> nanocapsules for hyperthermia applications</article-title>. <source>ACS Appl. Mat. Interfaces</source> <volume>8</volume>, <fpage>25043</fpage>&#x2013;<lpage>25050</lpage>. <pub-id pub-id-type="doi">10.1021/acsami.6b05917</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname>
<given-names>M. B.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y. J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Pu</surname>
<given-names>K. Y.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Bioenzyme-based nanomedicines for enhanced cancer therapy</article-title>. <source>Nano Converg.</source> <volume>9</volume>, <fpage>7</fpage>. <pub-id pub-id-type="doi">10.1186/s40580-022-00297-8</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname>
<given-names>T. X.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H. Y.</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>X. M.</given-names>
</name>
<name>
<surname>Niu</surname>
<given-names>J. M.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>PFP@PLGA/Cu12Sb4S13-mediated PTT ablates hepatocellular carcinoma by inhibiting the RAS/MAPK/MT-CO1 signaling pathway</article-title>. <source>Nano Converg.</source> <volume>8</volume>, <fpage>29</fpage>. <pub-id pub-id-type="doi">10.1186/s40580-021-00279-2</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Espinosa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Di Corato</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kolosnjaj-Tabi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Flaud</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Pellegrino</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wilhelm</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Duality of iron oxide nanoparticles in cancer therapy: Amplification of heating efficiency by magnetic hyperthermia and photothermal bimodal treatment</article-title>. <source>ACS Nano</source> <volume>10</volume>, <fpage>2436</fpage>&#x2013;<lpage>2446</lpage>. <pub-id pub-id-type="doi">10.1021/acsnano.5b07249</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goncalves</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Figueira</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Maciel</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Rodrigues</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>X. Y.</given-names>
</name>
<name>
<surname>Tomas</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Antitumor efficacy of doxorubicin-loaded laponite/alginate hybrid hydrogels</article-title>. <source>Macromol. Biosci.</source> <volume>14</volume>, <fpage>110</fpage>&#x2013;<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1002/mabi.201300241</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Griffin</surname>
<given-names>D. R.</given-names>
</name>
<name>
<surname>Weaver</surname>
<given-names>W. M.</given-names>
</name>
<name>
<surname>Scumpia</surname>
<given-names>P. O.</given-names>
</name>
<name>
<surname>Di Carlo</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Segura</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Accelerated wound healing by injectable microporous gel scaffolds assembled from annealed building blocks</article-title>. <source>Nat. Mat.</source> <volume>14</volume>, <fpage>737</fpage>&#x2013;<lpage>744</lpage>. <pub-id pub-id-type="doi">10.1038/nmat4294</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Facile synthesis of hyaluronic acid-modified Fe<sub>3</sub>O<sub>4</sub>/Au composite nanoparticles for targeted dual mode MR/CT imaging of tumors</article-title>. <source>J. Mat. Chem. B</source> <volume>3</volume>, <fpage>9098</fpage>&#x2013;<lpage>9108</lpage>. <pub-id pub-id-type="doi">10.1039/c5tb02040a</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jing</surname>
<given-names>Z. W.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>Q. Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X. J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Nanomedicines and nanomaterials for cancer therapy: Progress, challenge and perspectives</article-title>. <source>Chem. Eng. J.</source> <volume>446</volume>, <fpage>137147</fpage>. <pub-id pub-id-type="doi">10.1016/j.cej.2022.137147</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>D. H.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>D. C.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery</article-title>. <source>Biomaterials</source> <volume>27</volume>, <fpage>3031</fpage>&#x2013;<lpage>3037</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2005.12.021</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>K. Y.</given-names>
</name>
<name>
<surname>Mooney</surname>
<given-names>D. J.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Alginate: Properties and biomedical applications</article-title>. <source>Prog. Polym. Sci.</source> <volume>37</volume>, <fpage>106</fpage>&#x2013;<lpage>126</lpage>. <pub-id pub-id-type="doi">10.1016/j.progpolymsci.2011.06.003</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ocsoy</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Yasun</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>You</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Gold-coated Fe<sub>3</sub>O<sub>4</sub> nanoroses with five unique functions for cancer cell targeting, imaging and therapy</article-title>. <source>Adv. Funct. Mat.</source> <volume>24</volume>, <fpage>1772</fpage>&#x2013;<lpage>1780</lpage>. <pub-id pub-id-type="doi">10.1002/adfm.201301659</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Qing</surname>
<given-names>X. Q.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>N. Y.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>M. B.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z. H.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Oxygen-producing proenzyme hydrogels for photodynamic-mediated metastasis-inhibiting combinational therapy</article-title>. <source>J. Mat. Chem. B</source> <volume>9</volume>, <fpage>5255</fpage>&#x2013;<lpage>5263</lpage>. <pub-id pub-id-type="doi">10.1039/d1tb01009c</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>W. B.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>L. N.</given-names>
</name>
<name>
<surname>Nakayama</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>X. M.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>
<italic>In vivo</italic> biodistribution and highly efficient tumour targeting of carbon nanotubes in mice</article-title>. <source>Nat. Nanotechnol.</source> <volume>2</volume>, <fpage>47</fpage>&#x2013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1038/nnano.2006.170</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meng</surname>
<given-names>X. Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X. Z.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>N. Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z. F.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Fenton reaction-based nanomedicine in cancer chemodynamic and synergistic therapy</article-title>. <source>Appl. Mat. Today</source> <volume>21</volume>, <fpage>100864</fpage>. <pub-id pub-id-type="doi">10.1016/j.apmt.2020.100864</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Navya</surname>
<given-names>P. N.</given-names>
</name>
<name>
<surname>Kaphle</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Srinivas</surname>
<given-names>S. P.</given-names>
</name>
<name>
<surname>Bhargava</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Rotello</surname>
<given-names>V. M.</given-names>
</name>
<name>
<surname>Daima</surname>
<given-names>H. K.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Current trends and challenges in cancer management and therapy using designer nanomaterials</article-title>. <source>Nano Converg.</source> <volume>6</volume>, <fpage>23</fpage>. <pub-id pub-id-type="doi">10.1186/s40580-019-0193-2</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Puiggal&#xed;-Jou</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Babeli</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Roa</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Zoppe</surname>
<given-names>J. O.</given-names>
</name>
<name>
<surname>Garcia-Amor&#xf3;s</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ginebra</surname>
<given-names>M. P.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Remote spatiotemporal control of a magnetic and electroconductive hydrogel network via magnetic fields for soft electronic applications</article-title>. <source>ACS Appl. Mat. Interfaces</source> <volume>13</volume>, <fpage>42486</fpage>&#x2013;<lpage>42501</lpage>. <pub-id pub-id-type="doi">10.1021/acsami.1c12458</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shah</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Eldridge</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Palombo</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Harding</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Optimisation and stability assessment of solid lipid nanoparticles using particle size and zeta potential</article-title>. <source>J. Phys. Sci.</source> <volume>25</volume>, <fpage>59</fpage>&#x2013;<lpage>75</lpage>.</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shubayev</surname>
<given-names>V. I.</given-names>
</name>
<name>
<surname>Pisanic</surname>
<given-names>T. R.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>S. H.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Magnetic nanoparticles for theragnostics</article-title>. <source>Adv. Drug Deliv. Rev.</source> <volume>61</volume>, <fpage>467</fpage>&#x2013;<lpage>477</lpage>. <pub-id pub-id-type="doi">10.1016/j.addr.2009.03.007</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vegas</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Veiseh</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Doloff</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tam</surname>
<given-names>H. H.</given-names>
</name>
<name>
<surname>Bratlie</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Combinatorial hydrogel library enables identification of materials that mitigate the foreign body response in primates</article-title>. <source>Nat. Biotechnol.</source> <volume>34</volume>, <fpage>345</fpage>&#x2013;<lpage>352</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.3462</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Iron oxide nanoparticles with different polymer coatings for photothermal therapy</article-title>. <source>J. Nanopart. Res.</source> <volume>19</volume>, <fpage>333</fpage>. <pub-id pub-id-type="doi">10.1007/s11051-017-4031-3</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Pei</surname>
<given-names>Y. M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X. G.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>J. B.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Engineering of an intelligent cascade nanoreactor for sequential improvement of microenvironment and enhanced tumor phototherapy</article-title>. <source>Appl. Mat. Today</source> <volume>18</volume>, <fpage>100494</fpage>. <pub-id pub-id-type="doi">10.1016/j.apmt.2019.100494</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>